Literature DB >> 16233897

Matrix metalloproteinase 9 in the uterine cervix during tumor progression.

A Talvensaari-Mattila1, T Turpeenniemi-Hujanen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16233897     DOI： 10.1016/j.ijgo.2005.08.021

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN： 0020-7292            Impact factor:   3.561


× No keyword cloud information.
  5 in total

1.  Expression of matrix metalloproteinase-2 and 9 in cervical intraepithelial neoplasia and cervical carcinoma among different age groups of premenopausal and postmenopausal women.

Authors:  Arnab Ghosh; Anuradha Moirangthem; Rabindranath Dalui; TapanKumar Ghosh; Arghya Bandyopadhyay; Anindya Dasgupta; Uma Banerjee; Narayan Jana; Anupam Basu
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-08       Impact factor: 4.553

2.  Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells.

Authors:  Ilaria Bacigalupo; Clelia Palladino; Patrizia Leone; Elena Toschi; Cecilia Sgadari; Barbara Ensoli; Giovanni Barillari
Journal:  Oncol Lett       Date:  2017-03-09       Impact factor: 2.967

3.  PARP-1 depletion in combination with carbon ion exposure significantly reduces MMPs activity and overall increases TIMPs expression in cultured HeLa cells.

Authors:  Atanu Ghorai; Asitikantha Sarma; Priyanka Chowdhury; Utpal Ghosh
Journal:  Radiat Oncol       Date:  2016-09-22       Impact factor: 3.481

Review 4.  The Impact of Human Papilloma Viruses, Matrix Metallo-Proteinases and HIV Protease Inhibitors on the Onset and Progression of Uterine Cervix Epithelial Tumors: A Review of Preclinical and Clinical Studies.

Authors:  Giovanni Barillari; Paolo Monini; Cecilia Sgadari; Barbara Ensoli
Journal:  Int J Mol Sci       Date:  2018-05-09       Impact factor: 5.923

Review 5.  Alterations in the expression and activity of extracellular matrix components in HPV-associated infections and diseases.

Authors:  Suellen Herbster; Andressa Paladino; Sumara de Freitas; Enrique Boccardo
Journal:  Clinics (Sao Paulo)       Date:  2018-09-06       Impact factor: 2.365
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.